Results Summary and Professional Abstract
|Article Highlight: Earlier this decade, the use of direct-acting antivirals—which stop a virus from making copies of itself—was a breakthrough in the treatment of hepatitis C virus. But little research exists on possible side effects of the antivirals, especially among large, real-world populations. This study, which used PCORnet data, found that patients who took the antivirals were no more likely to experience adverse events than those who didn’t take them. The researchers published their findings in JAMA Network Open.|
|This project's final research report is expected to be available by May 2020.|
The Peer-Review Summary for this project will be posted here soon.
Conflict of Interest Disclosures
The COI disclosure form will be posted here soon.